Go Pro
→ Your $29.97 book is free today (From Profits Run) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Vaalco Energy Inc stock logo
EGY
Vaalco Energy
$5.33
-0.1%		$5.34
$3.36
▼
$6.72
$555.18M0.11.13 million shs932,958 shs
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
$10.08
$13.02
$9.62
▼
$21.34
$713.46M-0.019,228 shs26,888 shs
7 Best Space Stocks to Own in 2026 Cover
7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Vaalco Energy Inc stock logo
EGY
Vaalco Energy
0.00%-4.31%+5.34%-17.77%+47.92%
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
0.00%-20.03%-26.80%-40.64%-8.03%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Vaalco Energy Inc stock logo
EGY
Vaalco Energy
$5.33
-0.1%		$5.34
$3.36
▼
$6.72
$555.18M0.11.13 million shs932,958 shs
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
$10.08
$13.02
$9.62
▼
$21.34
$713.46M-0.019,228 shs26,888 shs
7 Best Space Stocks to Own in 2026 Cover
7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Vaalco Energy Inc stock logo
EGY
Vaalco Energy
0.00%-4.31%+5.34%-17.77%+47.92%
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
0.00%-20.03%-26.80%-40.64%-8.03%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Vaalco Energy Inc stock logo
EGY
Vaalco Energy
1.50
Reduce$7.3037.09% Upside
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
2.40
Hold$38.33280.29% Upside

Current Analyst Ratings Breakdown

Latest PHAR, ENQ, EGY, and GKP Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/30/2026
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
Oppenheimer Holdings, Inc. logo
Oppenheimer
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform
5/12/2026
Vaalco Energy Inc stock logo
EGY
Vaalco Energy
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold (C-) ➝ Sell (D+)
5/11/2026
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold (C-) ➝ Sell (D)
(Data available from 8/3/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Vaalco Energy Inc stock logo
EGY
Vaalco Energy
$359.27M1.55$1.02 per share5.24$4.25 per share1.25
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
$376.13M1.90$0.20 per share50.26$3.95 per share2.55
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Vaalco Energy Inc stock logo
EGY
Vaalco Energy
-$41.39M-$1.37N/A18.36N/A-45.86%-12.74%-6.14%8/6/2026 (Estimated)
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
$2.85M$0.1284.0020.16N/A2.51%3.40%1.88%N/A

Latest PHAR, ENQ, EGY, and GKP Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2026Q2 2026
Vaalco Energy Inc stock logo
EGY
Vaalco Energy
$0.0650N/AN/AN/A$116.25 millionN/A
7/30/2026Q2 2026
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
$0.0630$0.02-$0.0430$0.02$99.52 million$90.20 million
5/7/2026Q1 2026
Vaalco Energy Inc stock logo
EGY
Vaalco Energy
-$0.01-$0.45-$0.44-$0.90$78.20 million$62.60 million
5/7/2026Q1 2026
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
$0.05-$0.07-$0.12-$0.07$92.06 million$72.45 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Vaalco Energy Inc stock logo
EGY
Vaalco Energy
$0.254.69%N/AN/A N/A
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
N/AN/AN/AN/AN/A

Latest PHAR, ENQ, EGY, and GKP Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/7/2026
Vaalco Energy Inc stock logo
EGY
Vaalco Energy
quarterly$0.06254.37%5/22/20265/22/20266/26/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Vaalco Energy Inc stock logo
EGY
Vaalco Energy
0.60
0.51
0.47
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
0.35
2.63
2.06

Institutional Ownership

CompanyInstitutional Ownership
Vaalco Energy Inc stock logo
EGY
Vaalco Energy
50.32%
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
0.03%

Insider Ownership

CompanyInsider Ownership
Vaalco Energy Inc stock logo
EGY
Vaalco Energy
3.00%
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
2.07%
CompanyEmployeesShares OutstandingFree FloatOptionable
Vaalco Energy Inc stock logo
EGY
Vaalco Energy
120104.26 million101.13 millionOptionable
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
28070.78 million69.31 millionNot Optionable

Recent News About These Companies

HC Wainwright Lowers Earnings Estimates for Pharming Group
 |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30937173
Q3 EPS Estimates for Pharming Group Lowered by HC Wainwright
 |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/q3-eps-estimates-for-pharming-group-lowered-by-hc-wainwright-2026-08-03/
Pharming Group (NASDAQ:PHAR) Shares Gap Down After Earnings Miss
August 2 at 1:21 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30935266
Pharming Group (NASDAQ:PHAR) Hits New 12-Month Low Following Weak Earnings
August 1 at 1:20 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30933333
Pharming Group (NASDAQ:PHAR) Posts Earnings Results, Misses Expectations By $0.04 EPS
July 31 at 9:40 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/pharming-group-nasdaqphar-posts-earnings-results-misses-expectations-by-004-eps-2026-07-30/
Pharming Group Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Pharming Group (PHAR)
July 31 at 4:58 PM  |  prnewswire.comhttps://www.prnewswire.com/news-releases/pharming-group-investigation-notice-levi--korsinsky-notifies-investors-of-pending-investigation-into-pharming-group-phar-302840307.html
Pharming Group (NASDAQ:PHAR) Shares Gap Down Following Weak Earnings
July 31 at 10:21 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/pharming-group-nasdaqphar-shares-gap-down-following-weak-earnings-2026-07-31/
Pharming Group N.V. (PHAR) Q2 2026 Earnings Call Transcript
July 30, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4928101-pharming-group-n-v-phar-q2-2026-earnings-call-transcript
Pharming reports second quarter and first half 2026 financial results and revises year-end guidance; strong Joenja momentum and near-term clinical readouts to support broader ...
July 30, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/pharming-reports-second-quarter-and-first-half-2026-financial-results-and-revises-year-end-guidance-strong-joenja-momentum-and-near-term-clinical-readouts-to-support-broader-therapeutic-use-1036383406
Pharming Group下调2026年营收指引3000万美元，销售疲软拖累业绩
July 30, 2026  |  cn.investing.comhttps://cn.investing.com/news/stock-market-news/article-93CH-3487282
Pharming Group mist Q2 2026 omzetverwachting, aandeel daalt 22%
July 30, 2026  |  nl.investing.comhttps://nl.investing.com/news/transcripts/pharming-group-mist-q2-2026-omzetverwachting-aandeel-daalt-22-93CH-870710
Pharming Group (NASDAQ:PHAR) Sets New 12-Month Low Following Weak Earnings
July 30, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/pharming-group-nasdaqphar-sets-new-12-month-low-following-weak-earnings-2026-07-30/
Pharming Group Q2 Earnings Call Highlights
July 30, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/pharming-group-q2-earnings-call-highlights-2026-07-30/
Pharming Group N.V. 2026 Q2 - Results - Earnings Call Presentation
July 30, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4927633-pharming-group-n-v-2026-q2-results-earnings-call-presentation
Earnings To Watch: Pharming Group (XAMS:PHARM) Q2 2026 -- GF Value Sees 36% Upside
July 29, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/earnings-watch-pharming-group-xams-140027227.html
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Short Interest Update
July 27, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/pharming-group-nv-sponsored-adr-nasdaqphar-short-interest-update-2026-07-27/
Pharming Group (PHAR) to Release Earnings on Thursday
July 23, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/pharming-group-phar-to-release-earnings-on-thursday-2026-07-23/
Analysts Set Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Target Price at $38.33
July 22, 2026  |  defenseworld.netD
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Given Average Rating of "Hold" by Analysts
July 19, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/pharming-group-nv-sponsored-adr-nasdaqphar-given-average-rating-of-hold-by-analysts-2026-07-19/
Pharming Group to report second quarter and first half 2026 financial results and provide business update on July 30
July 16, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/pharming-group-report-second-quarter-060000607.html
Pharming Group (NASDAQ:PHAR) Shares Gap Down - Here's What Happened
July 15, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/pharming-group-nasdaqphar-shares-gap-down-heres-what-happened-2026-07-15/

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
A Starbucks cup with logo sits on a wooden counter inside a coffee shop with espresso equipment visible.
Starbucks Builds Sovereign AI to Cut $400 Million in Software Costs
By Jeffrey Neal Johnson | July 11, 2026
Illustration of two trees, one with gold coin leaves and one with green leaves and hanging dollar coins, symbolizing investment growth.
This Dividend ETF Choice Could Shape Your Income Strategy Through 2026
By Jessica Mitacek | July 12, 2026
Strategy logo with Bitcoin symbols and a key displayed on a glowing digital network surface.
Strategy’s Bitcoin Pivot Gives Investors a New Reason to Watch Preferred Shares
By Jeffrey Neal Johnson | July 5, 2026
Illustration of the Apple logo glowing on a circuit board encased in a translucent box against a digital backdrop.
Apple’s AI Toll Booth Thesis Faces Its Biggest Test Yet Before Earnings
By Sam Quirke | July 15, 2026
A gloved hand holds a white capsule pill in a pharmaceutical laboratory setting.
The Phase 3 Failure That Sent Biotech Winners and Losers in Opposite Directions
By Jeffrey Neal Johnson | July 13, 2026
Vaalco Energy stock logo

Vaalco Energy NYSE:EGY

$5.32 -0.01 (-0.09%)
Closing price 07/31/2026 03:59 PM Eastern
Extended Trading
$5.34 +0.01 (+0.19%)
As of 07/31/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

VAALCO Energy, Inc., an independent energy company, engages in the acquisition, exploration, development, and production of crude oil, natural gas, and natural gas liquids in Gabon, Egypt, Equatorial Guinea, and Canada. The company holds 58.8% interest in the Etame production sharing contract related to the Etame Marin block covering an area of approximately 46,200 gross acres located offshore in the Republic of Gabon in West Africa. It also owns 100% interest in the Eastern Desert, which contains West Gharib, West Bakr and North West Gharib merged concessions covering as area of approximately 45,067 acres, as well as Western Desert, which contains the South Ghazalat concession covering as area of approximately 7,340 acres located in Egypt. In addition, the company production and working interests in Cardium light oil and Mannville liquids-rich gas assets covering as area of 47,400 gross acres located near the north of Calgary, Alberta; and an undeveloped block offshore Equatorial Guinea, West Africa. VAALCO Energy, Inc. was incorporated in 1985 and is headquartered in Houston, Texas.

Pharming Group stock logo

Pharming Group NASDAQ:PHAR

$10.08 0.00 (0.00%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$10.20 +0.12 (+1.19%)
As of 07/31/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas